William Sutherland's questions to Surgery Partners Inc (SGRY) leadership • Q3 2024
Question
William Sutherland from The Benchmark Company asked for an update on the cardiology service line, particularly the growth of electrophysiology (EP) procedures. He also inquired about the status of de novo facility launches, including their timing and ownership structure.
Answer
CEO J. Evans described cardiology as a future high-growth area, noting that procedures like EP are easier to move into ASCs and that over 70% of their facilities are already equipped for them. CFO David Doherty added that the de novo pipeline remains a key growth lever, with 17 opened to date and more planned. He explained that most start as minority-interest partnerships, which offer excellent, low-cost capital deployment with favorable economics.